NF‐κB is one of the key signals in oncogenesis and development of human gliomas, and research is ongoing to identify selective and effective NF‐κB suppressors.2 The main regulatory mechanism of NF‐κB involves the IκB inhibitor that sequesters the NF‐κB complex in the cytosol. This evidence concerns the gene NFKB1 and central nervous system cancer.